{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T07:38:39Z","timestamp":1769153919161,"version":"3.49.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004330","name":"GSK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>A MenABCWY vaccine containing 4CMenB and MenACWY-CRM vaccine components has been developed to protect against the 5 meningococcal serogroups that cause most invasive disease cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this phase 3 study, healthy participants aged 15\u201325 years, who had received MenACWY vaccination \u22654 years previously, were randomized (1:1) to receive 2 MenABCWY doses 6 months apart or 1 MenACWY-CRM dose. Primary objectives were to demonstrate the noninferiority of MenABCWY 1 month postvaccination versus MenACWY-CRM, with a lower limit of 2-sided 95% confidence interval above \u221210% for group differences in 4-fold rise in human serum bactericidal antibody (hSBA) titers against serogroups ACWY, and to evaluate reactogenicity and safety. Secondary endpoints included percentages of participants with hSBA titers greater than or equal to the lower limit of quantitation (\u2265LLOQ) against serogroups ACWY and vaccine antigen-specific serogroup B (MenB) indicator strains.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Noninferiority of MenABCWY versus MenACWY-CRM was demonstrated following each MenABCWY dose. Percentages of participants with hSBA titers \u2265LLOQ for serogroups ACWY were 97.9%\u201398.9% and 99.5%\u2013100% following 1 and 2 MenABCWY doses, respectively, and 96.8%\u201399.0% following 1 MenACWY-CRM dose. After 2 MenABCWY doses, 75.6%\u201396.3% of participants had hSBA titers \u2265LLOQ against MenB indicator strains. The MenABCWY vaccine was well tolerated in MenACWY-primed individuals, with a favorable safety profile.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Immune responses against serogroups ACWY following 1 and 2 doses of investigational MenABCWY vaccine are noninferior to those following MenACWY-CRM in MenACWY-primed adolescents and young adults. Robust immune responses were observed against MenB indicator strains after 2 MenABCWY doses administered 6 months apart.<\/jats:p>\n                  <jats:p>Clinical Trials Registration. NCT04707391.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae622","type":"journal-article","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T07:33:42Z","timestamp":1735198422000},"page":"752-760","source":"Crossref","is-referenced-by-count":3,"title":["Immunogenicity, Reactogenicity, and Safety of a Pentavalent Meningococcal ABCWY Vaccine in Adolescents and Young Adults Who Had Previously Received a Meningococcal ACWY Vaccine: A Phase 3, Randomized Controlled Clinical Study"],"prefix":"10.1093","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6018-3863","authenticated-orcid":false,"given":"Terry","family":"Nolan","sequence":"first","affiliation":[{"name":"Peter Doherty Institute at the University of Melbourne , VIC ,","place":["Australia"]},{"name":"Murdoch Children's Research Institute , Melbourne, VIC ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6650-0142","authenticated-orcid":false,"given":"Chiranjiwi","family":"Bhusal","sequence":"additional","affiliation":[{"name":"GSK , Amsterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6793-8798","authenticated-orcid":false,"given":"Alejandro","family":"Hoberman","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine, Pittsburgh , Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrado J","family":"Llapur","sequence":"additional","affiliation":[{"name":"Hospital del Ni\u00f1o Jes\u00fas , San Miguel de Tucum\u00e1n ,","place":["Argentina"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Voloshyna","sequence":"additional","affiliation":[{"name":"Northside Health , Coffs Harbour, New South Wales ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4393-6293","authenticated-orcid":false,"given":"Ezekiel","family":"Fink","sequence":"additional","affiliation":[{"name":"Cedar Health Research, LLC , Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1072-7700","authenticated-orcid":false,"given":"Angela","family":"Gentile","sequence":"additional","affiliation":[{"name":"Hospital de Ni\u00f1os Dr Ricardo Gutierrez , Buenos Aires ,","place":["Argentina"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry","family":"Wallace","sequence":"additional","affiliation":[{"name":"Dawson Clinical Research , Guelph, Ontario ,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7562-7228","authenticated-orcid":false,"given":"Peter C","family":"Richmond","sequence":"additional","affiliation":[{"name":"University of Western Australia , Perth, Western Australia ,","place":["Australia"]},{"name":"Perth Children\u2019s Hospital , Perth, Western Australia ,","place":["Australia"]},{"name":"Vaccine Trials Group, Telethon Kids Institute , Nedlands, Western Australia ,","place":["Australia"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1510-1309","authenticated-orcid":false,"given":"Joseph B","family":"Domachowske","sequence":"additional","affiliation":[{"name":"State University of New York Upstate Medical University , Syracuse, New York"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9453-6302","authenticated-orcid":false,"given":"Thembile","family":"Mzolo","sequence":"additional","affiliation":[{"name":"GSK , Amsterdam ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3457-426X","authenticated-orcid":false,"given":"Maria","family":"Lattanzi","sequence":"additional","affiliation":[{"name":"GSK , Siena ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7661-4370","authenticated-orcid":false,"given":"Daniela","family":"Toneatto","sequence":"additional","affiliation":[{"name":"GSK , Siena ,","place":["Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the BOOST Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adebayo","family":"Akinsola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhavi","family":"Ampajwala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Arya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Bartlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Divya","family":"Batra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Theo","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Bordon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Byars","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy Peter James","family":"Carr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Ceballos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinandus","family":"de Looze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Deluca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Domachowske","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rand","family":"Farjo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezekiel","family":"Fink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Gilsoul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Anne","family":"Gunner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Hoberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Kasarjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrado Juan","family":"Llapur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darvy","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo Perez","family":"Marc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul G","family":"Matherne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terry","family":"Nolan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mora Nair","family":"Obed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"O\u0127Mahony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando Oscar","family":"Riera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Rok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Saravolatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Silas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana Elvira","family":"Soto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Surber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Augusto","family":"Teijeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florence","family":"Tiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Voloshyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ushma","family":"Wadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garry","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford","family":"Yut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,26]]},"reference":[{"key":"2025043020394979100_ciae622-B1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s40121-023-00906-x","article-title":"The diverse spectrum of invasive meningococcal disease in pediatric and adolescent patients: narrative review of cases and case series","volume":"13","author":"Bobde","year":"2024","journal-title":"Infect Dis Ther"},{"key":"2025043020394979100_ciae622-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/23744235.2021.1971289","article-title":"Global epidemiology and changing clinical presentations of invasive meningococcal disease: a narrative review","volume":"54","author":"Deghmane","year":"2022","journal-title":"Infect Dis (Lond)"},{"key":"2025043020394979100_ciae622-B3","article-title":"Meningococcal disease surveillance and trends","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2025043020394979100_ciae622-B4","article-title":"Invasive meningococcal disease. Annual epidemiological report for 2022","author":"European Centre for Disease Prevention and Control","year":"2022"},{"key":"2025043020394979100_ciae622-B5","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jinf.2020.05.079","article-title":"The everchanging epidemiology of meningococcal disease worldwide and the potential for prevention through vaccination","volume":"81","author":"Parikh","year":"2020","journal-title":"J Infect"},{"key":"2025043020394979100_ciae622-B6","article-title":"Penbraya [product information]","author":"US Food and Drug Administration","year":"2024"},{"key":"2025043020394979100_ciae622-B7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.jinf.2022.09.001","article-title":"Public health perspective of a pentavalent meningococcal vaccine combining antigens of MenACWY-CRM and 4CMenB","volume":"85","author":"Bekkat-Berkani","year":"2022","journal-title":"J Infect"},{"key":"2025043020394979100_ciae622-B8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6909a1","article-title":"Meningococcal vaccination: recommendations of the Advisory Committee on Immunization Practices, United States, 2020","volume":"69","author":"Mbaeyi","year":"2020","journal-title":"MMWR Recomm Rep"},{"key":"2025043020394979100_ciae622-B9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jadohealth.2019.04.021","article-title":"Meningococcal conjugate vaccine in the United States: remaining challenges for adolescent vaccination","volume":"65","author":"Mbaeyi","year":"2019","journal-title":"J Adolesc Health"},{"key":"2025043020394979100_ciae622-B10","doi-asserted-by":"crossref","first-page":"912","DOI":"10.15585\/mmwr.mm7234a3","article-title":"Vaccination coverage among adolescents aged 13\u201317 years\u2014National Immunization Survey\u2013Teen, United States, 2022","volume":"72","author":"Pingali","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025043020394979100_ciae622-B11","doi-asserted-by":"crossref","first-page":"2186111","DOI":"10.1080\/21645515.2023.2186111","article-title":"Changing patterns of invasive meningococcal disease and future immunization strategies","volume":"19","author":"Taha","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"2025043020394979100_ciae622-B12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.15585\/mmwr.mm7315a4","article-title":"Use of the Pfizer pentavalent meningococcal vaccine among persons aged \u226510 years: recommendations of the Advisory Committee on Immunization Practices\u2014United States, 2023","volume":"73","author":"Collins","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025043020394979100_ciae622-B13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1080\/14760584.2018.1547637","article-title":"Meningococcal B vaccine (4CMenB): the journey from research to real world experience","volume":"17","author":"Rappuoli","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2025043020394979100_ciae622-B14","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/14760584.2018.1483726","article-title":"From research to licensure and beyond: clinical development of MenB-FHbp, a broadly protective meningococcal B vaccine","volume":"17","author":"Perez","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"2025043020394979100_ciae622-B15","doi-asserted-by":"crossref","first-page":"2357924","DOI":"10.1080\/21645515.2024.2357924","article-title":"4CMenB journey to the 10-year anniversary and beyond","volume":"20","author":"Abitbol","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"2025043020394979100_ciae622-B16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1586\/erv.10.147","article-title":"Menveo: a novel quadrivalent meningococcal CRM197 conjugate vaccine against serogroups A, C, W-135 and Y","volume":"10","author":"Cooper","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"Suppl 2","key":"2025043020394979100_ciae622-B17","doi-asserted-by":"crossref","first-page":"B87","DOI":"10.1016\/j.vaccine.2012.01.033","article-title":"The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens","volume":"30","author":"Serruto","year":"2012","journal-title":"Vaccine"},{"key":"2025043020394979100_ciae622-B18","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40121-021-00519-2","article-title":"A decade of fighting invasive meningococcal disease: a narrative review of clinical and real-world experience with the MenACWY-CRM conjugate vaccine","volume":"11","author":"Ruiz Garcia","year":"2022","journal-title":"Infect Dis Ther"},{"key":"2025043020394979100_ciae622-B19","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1016\/j.vaccine.2015.03.001","article-title":"A comparative evaluation of two investigational meningococcal ABCWY vaccine formulations: results of a phase 2 randomized, controlled trial","volume":"33","author":"Block","year":"2015","journal-title":"Vaccine"},{"key":"2025043020394979100_ciae622-B20","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1080\/21645515.2015.1029686","article-title":"Immunogenicity and safety of investigational vaccine formulations against meningococcal serogroups A, B, C, W, and Y in healthy adolescents","volume":"11","author":"S\u00e1ez-Llorens","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"2025043020394979100_ciae622-B21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/21645515.2018.1457595","article-title":"Four-year antibody persistence and response to a booster dose of a pentavalent MenABCWY vaccine administered to healthy adolescents and young adults","volume":"14","author":"S\u00e1ez-Llorens","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"2025043020394979100_ciae622-B22","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1016\/j.vaccine.2018.07.016","article-title":"Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents\u2014results from a randomized, controlled, observer-blind phase II study","volume":"36","author":"Welsch","year":"2018","journal-title":"Vaccine"},{"key":"2025043020394979100_ciae622-B23","doi-asserted-by":"crossref","first-page":"4689","DOI":"10.1080\/21645515.2021.1968214","article-title":"Immunogenicity and safety of different schedules of the meningococcal ABCWY vaccine, with assessment of long-term antibody persistence and booster responses\u2014results from two phase 2b randomized trials in adolescents","volume":"17","author":"Vesikari","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"2025043020394979100_ciae622-B24","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/INF.0000000000001896","article-title":"Immune responses to booster vaccination with meningococcal ABCWY vaccine after primary vaccination with either investigational or licensed vaccines: a phase 2 randomized study","volume":"37","author":"Szenborn","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"2025043020394979100_ciae622-B25","doi-asserted-by":"crossref","first-page":"e0055321","DOI":"10.1128\/mSphere.00553-21","article-title":"Immunogenicity and safety of investigational MenABCWY vaccine and of 4CMenB and MenACWY vaccines administered concomitantly or alone: a phase 2 randomized study of adolescents and young adults","volume":"6","author":"Beran","year":"2021","journal-title":"mSphere"},{"key":"2025043020394979100_ciae622-B26","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.1097\/INF.0000000000000822","article-title":"Persistence of meningococcal antibodies and response to a third dose after a two-dose vaccination series with investigational MenABCWY vaccine formulations in adolescents","volume":"34","author":"S\u00e1ez-Llorens","year":"2015","journal-title":"Pediatr Infect Dis J"},{"key":"2025043020394979100_ciae622-B27","article-title":"Effectiveness, immunogenicity and safety of a pentavalent meningococcal ABCWY vaccine in adolescents and young adults: results from a phase 3, randomized, controlled clinical study","author":"Nolan"},{"key":"2025043020394979100_ciae622-B28","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","article-title":"A multi-component meningococcal serogroup B vaccine (4CMenB): the clinical development program","volume":"74","author":"O\u2019Ryan","year":"2014","journal-title":"Drugs"},{"key":"2025043020394979100_ciae622-B29","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.vaccine.2013.01.042","article-title":"Optimal approaches to data collection and analysis of potential immune mediated disorders in clinical trials of new vaccines","volume":"31","author":"Tavares Da Silva","year":"2013","journal-title":"Vaccine"},{"key":"2025043020394979100_ciae622-B30","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/biomet\/26.4.404","article-title":"The use of confidence or fiducial limits illustrated in the case of the binomial","volume":"26","author":"Clopper","year":"1934","journal-title":"Biometrika"},{"key":"2025043020394979100_ciae622-B31","article-title":"Clinical trial results: a phase III, randomized, controlled, observer-blind study to demonstrate effectiveness, immunogenicity and safety of GSK\u2019s meningococcal group B and combined ABCWY vaccines when administered to healthy adolescents and young adults","author":"EU Clinical Trials Register","year":"2022"},{"key":"2025043020394979100_ciae622-B32","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-021-00286-8","article-title":"Endogenous complement human serum bactericidal assay (enc-hSBA) for vaccine effectiveness assessments against meningococcal serogroup B","volume":"6","author":"Kleinschmidt","year":"2021","journal-title":"NPJ Vaccines"},{"key":"2025043020394979100_ciae622-B33","doi-asserted-by":"crossref","first-page":"e0038522","DOI":"10.1128\/msphere.00385-22","article-title":"Genetic features of a representative panel of 110 meningococcal B isolates to assess the efficacy of meningococcal B vaccines","volume":"7","author":"Muzzi","year":"2022","journal-title":"mSphere"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae622\/61275832\/ciae622.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/752\/61275832\/ciae622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/80\/4\/752\/61275832\/ciae622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:39:58Z","timestamp":1746059998000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/80\/4\/752\/7932666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,26]]},"references-count":33,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,12,26]]},"published-print":{"date-parts":[[2025,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae622","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4,15]]},"published":{"date-parts":[[2024,12,26]]}}}